Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Is there a difference between patients with peak oxygen consumption during exercise below 10 ml/kg/min and between 10 and 14 ml/kg/min? Does the „grey zone” really exist?

M Lizak, M Zakliczyński, A Jarosz, A Barańska-Kosakowska, M Zembala

Ann Transplant 2009; 14(1): 32-32 :: ID: 880523

Abstract

Background: Maximal oxygen uptake is an important component of evaluation when orthotopic heart transplantation (OHT) in a chronic heart failure patient is considered. Authors call into question the accuracy of peak oxygen consumption during exercise (V02max) interpretation used at present.
Material/Methods: 302 patients with chronic heart failure were analysed in 3 groups according to V02max (ml/kg/min) - group 1: <10 (37 patients), group 2: 10-14 (121 patients), group 3: >14 (144 patients). Mean observation time was 3.41 years. Mortality, number of OHT, time to OHT if transplantation was performed, time to death and pulmonary function tests (PFT) were compared between the groups. ANOVA rang Kruskan-Wallis test was used for analysis in Statistica 7.1.
Results: There were no important differences in mortality (48.6 vs. 33.1%), number of OHT (24.3 vs. 32.2%), time to OHT (4.6 vs. 6.9 months), time to death (15.4 vs. 16.6 months) or pulmonary function tests (forced expiratory volume in the first second - FEV1: 2.29 vs. 2.58l and 69 vs. 77%, forced vital capacity - FVC: 2.97 vs. 3.32l and 73 vs. 81%, FEV1 to FVC ratio - FEV1%FVC: 76 vs. 77%, peak expiratory fl ow - PEF: 6.06 vs. 6.19l and 73 vs. 75%, all given as direct values and as percents of normal values) between group 1 and 2 (p>0.05) but group's 3 mortality (21.5%), number of OHT (14.6%), time to death (34.4 months) and pulmonary function tests (FEV1: 3.10l and 88%, FVC: 3.94l and 91%, PEF: 7.40l and 87%) differed significantly when compared to groups 1 and 2 (p<0.05). Percent of vital capacity normal value (VC%) differed significantly between all the groups (72 vs. 81 vs. 91% accordingly).
Conclusions: No convincing reasons to feel less worried about patients with V02max between 10-14 then below 10 ml/kg/min were found in this research. Analysis of PFT could show additional specifi c risk factors in the chronic heart failure.

Keywords: Heart Transplantation, clinical outcome

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358